XGN - Exagen licenses lupus nephritis biomarkers from Johns Hopkins November, 09 2023 06:23 PM Exagen Inc. 2023-11-09 18:23:40 ET More on Exagen Seeking Alpha’s Quant Rating on Exagen Historical earnings data for Exagen Financial information for Exagen For further details see: Exagen licenses lupus nephritis biomarkers from Johns Hopkins